Načítá se...
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
Recent advances in remission induction treatment strategies for acute myeloid leukemia (AML) have improved the rates of complete remission (CR) and overall survival (OS), owing to a concerted effort to tailor therapies toward specific AML subtypes. However, without effective post-remission therapy,...
Uloženo v:
| Vydáno v: | Best Pract Res Clin Haematol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6903406/ https://ncbi.nlm.nih.gov/pubmed/31779969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2019.101102 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|